EVEREST ORGANICS
Back to Cashflow Statement
|
EVEREST ORGANICS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹4.17 Cr | ₹-5.38 Cr | ₹16 Cr | ₹18 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of EVEREST ORGANICS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹4.17 Cr |
| Mar2025 | ₹-5.38 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹14 Cr |
How is Cash Flow from Operating Activities of EVEREST ORGANICS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.17 Cr | Positive | |
| Mar2025 | ₹-5.38 Cr | Negative | |
| Mar2024 | ₹16 Cr | -12.61 | |
| Mar2023 | ₹18 Cr | 34.06 | |
| Mar2022 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹234.1 Cr | -8.2% | 4.3% | -35.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,944.0 Cr | -2% | 6% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹294,962.0 Cr | -4% | 22.9% | 75.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,391.0 Cr | -1.8% | 1.8% | 21.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,267.0 Cr | -0.4% | 13.1% | 13.7% | Stock Analytics | |
| CIPLA | ₹112,620.0 Cr | -0.9% | 4.5% | -8% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -8.2% |
4.3% |
-35.7% |
| SENSEX | 1.4% |
12.8% |
-1.7% |
You may also like the below Video Courses